These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23431246)

  • 1. An anti-inflammatory sterol decreases obesity-related inflammation-induced insulin resistance and metabolic dysregulation.
    Reading CL; Flores-Riveros J; Stickney DR; Frincke JM
    Mediators Inflamm; 2013; 2013():814989. PubMed ID: 23431246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic anti-inflammatory sterol improves insulin sensitivity in insulin-resistant obese impaired glucose tolerance subjects.
    Reading CL; Stickney DR; Flores-Riveros J; Destiche DA; Ahlem CN; Cefalu WT; Frincke JM
    Obesity (Silver Spring); 2013 Sep; 21(9):E343-9. PubMed ID: 23670958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.
    Lu M; Patsouris D; Li P; Flores-Riveros J; Frincke JM; Watkins S; Schenk S; Olefsky JM
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1036-48. PubMed ID: 20159859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sea cucumbers-derived sterol sulfate alleviates insulin resistance and inflammation in high-fat-high-fructose diet-induced obese mice.
    Zhang HJ; Chen C; Ding L; Shi HH; Wang CC; Xue CH; Zhang TT; Wang YM
    Pharmacol Res; 2020 Oct; 160():105191. PubMed ID: 32911073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of glucose intolerance by the synthetic androstene HE3286: link to inflammatory pathways.
    Wang T; Villegas S; Huang Y; White SK; Ahlem C; Lu M; Olefsky JM; Reading C; Frincke JM; Alleva D; Flores-Riveros J
    J Pharmacol Exp Ther; 2010 Apr; 333(1):70-80. PubMed ID: 20068030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
    Esser N; Paquot N; Scheen AJ
    Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do anti-inflammatory therapies fail to improve insulin sensitivity?
    Gao ZG; Ye JP
    Acta Pharmacol Sin; 2012 Feb; 33(2):182-8. PubMed ID: 22036866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Serum TNF-
    Alzamil H
    J Obes; 2020; 2020():5076858. PubMed ID: 32089876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
    Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.
    Stagi S; Ricci F; Bianconi M; Sammarco MA; Municchi G; Toni S; Lenzi L; Verrotti A; de Martino M
    Nutrients; 2017 May; 9(5):. PubMed ID: 28531113
    [No Abstract]   [Full Text] [Related]  

  • 16. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
    Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
    Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance.
    Kiefer FW; Zeyda M; Gollinger K; Pfau B; Neuhofer A; Weichhart T; Säemann MD; Geyeregger R; Schlederer M; Kenner L; Stulnig TM
    Diabetes; 2010 Apr; 59(4):935-46. PubMed ID: 20107108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.
    Garbossa SG; Folli F
    Rev Endocr Metab Disord; 2017 Jun; 18(2):243-258. PubMed ID: 28409320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.